Before knowing what Boniva (Ibandronate) is all about, let us first know about the disease it treats. Osteoporosis is a bone-related condition that weakens bones, brings bone mass down, and makes them more porous. It is mostly found in postmenopausal women due to deficiency of calcium in their bodies. Bone fractures, especially in the forearm, hip and vertebrae, can also occur in people with prolonged osteoporosis. If we'll go by the statistics of the International Osteoporosis Foundation, treating this disease with Boniva (Ibandronate) can lower your vertebral facture by 30 to 65 percent and fractures in other parts of the body by 16 to 70 percent.

 

What is Ibandronate?

 

Bearing the US brand name Boniva, Ibandronate belongs to the class of drugs known as bisphosphonates that change the cycle of bone formation and breakdown in the body. This prescription drug is used to treat or prevent osteoporosis in women who have gone through their menopause. Boniva works by decelerating the process of further bone loss while increasing bone mass. As a result, there may be less possibility of breaking bones (fractures). This medication is quite effective against osteoporosis, even though patients will be unable to see or experience any notable difference.